2017 Q4 Form 10-Q Financial Statement
#000114420418005155 Filed on February 01, 2018
Income Statement
Concept | 2017 Q4 | 2016 Q4 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | $0.00 | $0.00 |
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $1.000M | $1.030M |
YoY Change | -2.91% | 18.39% |
% of Gross Profit | ||
Research & Development | $580.9K | $349.3K |
YoY Change | 66.3% | -15.63% |
% of Gross Profit | ||
Depreciation & Amortization | $724.00 | $119.00 |
YoY Change | 508.4% | |
% of Gross Profit | ||
Operating Expenses | $1.582M | $1.376M |
YoY Change | 15.0% | 7.54% |
Operating Profit | -$1.582M | -$1.376M |
YoY Change | 15.0% | 7.54% |
Interest Expense | $0.00 | $25.57K |
YoY Change | -100.0% | -82.21% |
% of Operating Profit | ||
Other Income/Expense, Net | ||
YoY Change | ||
Pretax Income | $390.0K | -$1.400M |
YoY Change | -127.86% | 20.69% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | $389.2K | -$1.402M |
YoY Change | -127.77% | 21.17% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | $0.00 | -$0.01 |
Diluted Earnings Per Share | $0.00 | -$0.01 |
COMMON SHARES | ||
Basic Shares Outstanding | 150.1M shares | 135.3M shares |
Diluted Shares Outstanding | 163.5M shares | 135.3M shares |
Balance Sheet
Concept | 2017 Q4 | 2016 Q4 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $4.960M | $3.790M |
YoY Change | 30.87% | 34.4% |
Cash & Equivalents | $4.958M | $3.788M |
Short-Term Investments | ||
Other Short-Term Assets | $70.00K | $110.0K |
YoY Change | -36.36% | 120.0% |
Inventory | ||
Prepaid Expenses | $71.40K | |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $5.029M | $3.898M |
YoY Change | 29.03% | 35.89% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $9.927K | $4.174K |
YoY Change | 137.83% | |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $3.500K | |
YoY Change | ||
Total Long-Term Assets | $13.43K | $4.174K |
YoY Change | 221.68% | |
TOTAL ASSETS | ||
Total Short-Term Assets | $5.029M | $3.898M |
Total Long-Term Assets | $13.43K | $4.174K |
Total Assets | $5.043M | $3.902M |
YoY Change | 29.24% | 36.03% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $289.3K | $270.0K |
YoY Change | 7.14% | 0.8% |
Accrued Expenses | $180.0K | $380.0K |
YoY Change | -52.63% | 153.33% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $750.0K | |
YoY Change | 177.78% | |
Total Short-Term Liabilities | $470.5K | $1.410M |
YoY Change | -66.62% | 88.29% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | -100.0% | |
Other Long-Term Liabilities | $1.460M | $0.00 |
YoY Change | -100.0% | |
Total Long-Term Liabilities | $1.458M | $0.00 |
YoY Change | -100.0% | |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $470.5K | $1.410M |
Total Long-Term Liabilities | $1.458M | $0.00 |
Total Liabilities | $1.929M | $1.410M |
YoY Change | 36.81% | -28.01% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$29.11M | |
YoY Change | ||
Common Stock | $32.23M | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $3.114M | $2.490M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $5.043M | $3.900M |
YoY Change | 29.31% | 35.96% |
Cashflow Statement
Concept | 2017 Q4 | 2016 Q4 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $389.2K | -$1.402M |
YoY Change | -127.77% | 21.17% |
Depreciation, Depletion And Amortization | $724.00 | $119.00 |
YoY Change | 508.4% | |
Cash From Operating Activities | -$1.096M | -$1.375M |
YoY Change | -20.3% | 20.61% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $3.463K | $4.293K |
YoY Change | -19.33% | |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | -$3.463K | -$4.293K |
YoY Change | -19.33% | |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | $63.39K | $130.6K |
YoY Change | -51.45% | |
NET CHANGE | ||
Cash From Operating Activities | -$1.096M | -$1.375M |
Cash From Investing Activities | -$3.463K | -$4.293K |
Cash From Financing Activities | $63.39K | $130.6K |
Net Change In Cash | -$1.036M | -$1.249M |
YoY Change | -17.04% | 9.54% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$1.096M | -$1.375M |
Capital Expenditures | $3.463K | $4.293K |
Free Cash Flow | -$1.099M | -$1.379M |
YoY Change | -20.3% | 20.99% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2016Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
1375931 | USD |
CY2017Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
1582373 | USD |
CY2017Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
|
1971549 | USD |
CY2017Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
71404 | USD |
CY2017Q3 | us-gaap |
Cash
Cash
|
5994052 | USD |
CY2017Q4 | us-gaap |
Cash
Cash
|
4958073 | USD |
CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
9927 | USD |
CY2016Q4 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2017Q4 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2016Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1026644 | USD |
CY2017Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1001511 | USD |
CY2016Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
349287 | USD |
CY2017Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
580862 | USD |
CY2016Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1375931 | USD |
CY2017Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1582373 | USD |
CY2016Q4 | us-gaap |
Interest Expense
InterestExpense
|
25570 | USD |
CY2017Q4 | us-gaap |
Interest Expense
InterestExpense
|
0 | USD |
CY2016Q4 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-25570 | USD |
CY2017Q4 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
1971549 | USD |
CY2017Q4 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
CY2017Q4 | dei |
Trading Symbol
TradingSymbol
|
ARTH | |
CY2018Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
154052013 | shares |
CY2017Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
1458484 | USD |
CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
1929001 | USD |
CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
470517 | USD |
CY2017Q3 | us-gaap |
Assets
Assets
|
6090083 | USD |
CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
150302 | USD |
CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
32077871 | USD |
CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-29114270 | USD |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3113903 | USD |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5042904 | USD |
CY2017Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
433531 | USD |
CY2017Q3 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
168655 | USD |
CY2017Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
264876 | USD |
CY2017Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
3430033 | USD |
CY2017Q3 | us-gaap |
Liabilities
Liabilities
|
3863564 | USD |
CY2017Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
149943 | USD |
CY2017Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
31580022 | USD |
CY2017Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-29503446 | USD |
CY2017Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2226519 | USD |
CY2017Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
6090083 | USD |
CY2017Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
181241 | USD |
CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
289276 | USD |
CY2017Q4 | us-gaap |
Assets
Assets
|
5042904 | USD |
CY2017Q3 | us-gaap |
Assets Current
AssetsCurrent
|
6079395 | USD |
CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
5029477 | USD |
CY2017Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
85343 | USD |
CY2017Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7188 | USD |
CY2017Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
13427 | USD |
CY2017Q3 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
10688 | USD |
CY2017Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
1458484 | USD |
CY2017Q3 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
3430033 | USD |
CY2016Q4 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
265662 | USD |
CY2017Q4 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
434820 | USD |
CY2016Q4 | arth |
Noncash Interest Expense On Notes Payable
NoncashInterestExpenseOnNotesPayable
|
5529 | USD |
CY2017Q4 | arth |
Noncash Interest Expense On Notes Payable
NoncashInterestExpenseOnNotesPayable
|
0 | USD |
CY2016Q4 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
2286 | USD |
CY2017Q4 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-13939 | USD |
CY2016Q4 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-102644 | USD |
CY2017Q4 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
24400 | USD |
CY2016Q4 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-178451 | USD |
CY2017Q4 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
12586 | USD |
CY2016Q4 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1375002 | USD |
CY2017Q4 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1095904 | USD |
CY2016Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
130556 | USD |
CY2017Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
63388 | USD |
CY2016Q4 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-69430 | USD |
CY2016Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
|
0 | USD |
CY2017Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
389176 | USD |
CY2017Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0 | |
CY2016Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
CY2017Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
150144575 | shares |
CY2016Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
135319847 | shares |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-1248739 | USD |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-1035979 | USD |
CY2016Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5036476 | USD |
CY2017Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5994052 | USD |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3787737 | USD |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4958073 | USD |
CY2016Q4 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
359150 | USD |
CY2017Q4 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
63388 | USD |
CY2016Q4 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
0 | USD |
CY2017Q4 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
-1971549 | USD |
CY2017Q4 | us-gaap |
Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
|
0 | USD |
CY2016Q4 | us-gaap |
Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
|
-108000 | USD |
CY2017Q4 | us-gaap |
Depreciation
Depreciation
|
724 | USD |
CY2016Q4 | us-gaap |
Depreciation
Depreciation
|
119 | USD |
CY2017Q4 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
0 | USD |
CY2017Q4 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3463 | USD |
CY2016Q4 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4293 | USD |
CY2017Q4 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3463 | USD |
CY2016Q4 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4293 | USD |
CY2017Q4 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD |
CY2016Q4 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
228594 | USD |
CY2017Q4 | us-gaap |
Stock Issued1
StockIssued1
|
117 | USD |
CY2016Q4 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets
|
6147 | USD |
CY2017Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets
|
5423 | USD |
CY2013Q2 | arth |
Increase In Aggregate Number Of Shares
IncreaseInAggregateNumberOfShares
|
3000000 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.7226 | pure |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.1944 | pure |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0114 | pure |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | pure |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0240 | pure |
CY2017Q4 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
|
0.00 | pure |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2017Q4 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
225000 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
0 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.37 | |
CY2017Q4 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Awarded Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAwardedWeightedAverageRemainingContractualTerm
|
P0Y | |
CY2017Q4 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
|
P0Y | |
CY2017Q4 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm
|
P0Y | |
CY2017Q4 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Awarded Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAwardedAggregateIntrinsicValue
|
0 | USD |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | USD |
CY2017Q4 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodAggregateIntrinsicValue
|
0 | USD |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0 | |
CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
6178263 | USD |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1299763 | USD |
CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
14634210 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
14409210 | shares |
CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.39 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.39 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
4428980 | shares |
CY2016Q4 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
5500 | USD |
CY2017Q4 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
0 | USD |
CY2014Q4 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
224000 | USD |
CY2015Q2 | us-gaap |
Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
|
3263753 | USD |
CY2015Q1 | arth |
Gain Loss On Warrant Derivative Modification
GainLossOnWarrantDerivativeModification
|
624016 | USD |
CY2017Q1 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
2996110 | USD |
CY2017Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3500 | USD |
CY2017Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3500 | USD |
CY2017Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2017Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2017Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
154052013 | shares |
CY2017Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
138182075 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
154052013 | shares |
CY2017Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
138182075 | shares |
CY2017Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0 | |
CY2016Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
CY2017Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
163527032 | shares |
CY2016Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
135319847 | shares |
CY2017Q4 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left"><u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left">Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2017Q4 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Concentration of Credit Risk</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash. The Company maintains its cash in bank deposits accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2017Q4 | us-gaap |
Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left"><u>Derivative Liabilities</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left">The Company accounts for its warrants and other derivative financial instruments as either equity or liabilities based upon the characteristics and provisions of each instrument, in accordance with FASB ASC Topic 815, Derivatives and Hedging. Warrants classified as equity are recorded at fair value as of the date of issuance on the Company’s consolidated balance sheets and no further adjustments to their valuation are made. Warrants classified as derivative liabilities and other derivative financial instruments that require separate accounting as liabilities are recorded on the Company’s consolidated balance sheets at their fair value on the date of issuance and will be revalued on each subsequent balance sheet date until such instruments are exercised or expire, with any changes in the fair value between reporting periods recorded as other income or expense. Management estimates the fair value of these liabilities using option pricing models and assumptions that are based on the individual characteristics of the warrants or instruments on the valuation date, as well as assumptions for expected volatility, expected life, yield, and risk-free interest rate.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2017Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
12611 | USD |
CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
16074 | USD |
CY2017Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y8M19D | |
CY2017Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P4Y6M4D | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
12120302 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.36 | |
CY2017Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
1237915 | USD |
CY2017Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
0 | USD |
CY2017Q3 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
0 | USD |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
14409210 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
1299763 | USD |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
0.39 | |
CY2017Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P4Y9M18D |